Novel proteins have been elaborated over evolutionary time by an iterative alternation of mutation and selection. In a similar way, the humoral immune system also uses an iterative alternation of mutation and selection to generate novel antibodies that display a high affinity for their cognate antigen -but this is achieved in a matter of a days. Gene rearrangement is used to produce a primary repertoire of antibodies and, on entering the body, antigen triggers the clonal expansion of those B lymphocytes that express a cognate antibody, albeit one of low affinity. Rapid and specific affinity maturation is then achieved by subjecting the immunoglobulin genes in the rapidly expanding B cells to a period of intense mutation. T h e intensity of this mutational assault is tolerated because it is targeted specifically to the immunoglobulin genes, causing relatively little damage to other loci. Antigen-mediated selection then allows the preferential expansion of those mutants expressing antibodies displaying improved binding characteristics. Here, studies are described that have been performed to glean insight into the mechanisms of the hypermutation and selection processes. Experiments are also described in which an attempt has been made to recapitulate aspects of physiological antibody generation in vitro, allowing the development of novel approaches to the generation of proteins with high-affinity binding sites.
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Biochemical Society Transactions (2002) Volume 30, part 4 self (e.g. lipopolysaccharides, high-mannosecontaining oligosaccharides, etc.). T h e problem, of course, with such a strategy is that it invites evasion through mutation. It is presumably this limitation of innate recognition that has driven the evolution of adaptive immunity.
T h e humoral arm of the adaptive immune system is mediated by antibodies. Gene rearrangement at the immunoglobulin loci during lymphoid development generates a repertoire of B lymphocytes that express a diversity of antigen receptors gene segments is somewhat imprecise, and nucleotides may be inserted at the junction in a non-templated manner. There is therefore a very high degree of resultant diversity at the V-D-J borders. This contributes in a major way to the structural diversity of the third complementaritydetermining region of the antibody -a region that often plays a critical role in antigen recognition.
This primary repertoire of IgM antibodies comprises a few million different structures. T h e size of this repertoire means that any incoming antigen is likely to find an antibody that recognizes it with passable affinity -probably something in the range of lo5 M-'. A high-affinity binding site is unlikely to be available for most incoming antigens (the repertoire is not large enough)-but the affinity of the available IgM antibodies in the primary repertoire will clearly vary from antigen to antigen. If an epitope is re-iterated at high density on the surface of the antigen (e.g. a repeated structure on the surface of a virus or bacterium), then an IgM antibody may nevertheless be effective in mediating clearance of the organism, despite the low affinity of the individual Antibodies: a Paradigm for the Evolution of Molecular Recognition interaction between antigenicepitope and immunoglobulin combining site; the density of the epitopes may allow multivalent interactions with IgM, leading to a high-avidity interaction, providing that a suitable spacing of antigenic epitopes can occur. However, to ensure an effective and specific response, especially when the concentration of antigen is low (as may occur when the body is faced with a very small number of infecting viral particles), it would be greatly advantageous if high-affinity antibodies were available for neutralizing the infecting organism. T h e size of the primary repertoire mitigates against the likelihood of such high-affinity antibodies being present in this repertoire. T h e immune system therefore operates using a two-stage strategy (Figure 1 ).
T h e primary repertoire of IgM antibodies is generated by a process of gene rearrangement and takes place prior to antigen encounter during early lymphocyte development. However, once foreign antigen has been encountered, those B cells in the Figure 2 The secondary antibody repertoire accumulates in serum with age (Figure 2 ).
Evolution of high-affinity binding sites
T h e creation of proteins that bind their ligands with high affinity is a challenge that must go back to the earliest forms of life. Typically, the genes encoding novel proteins appear to have been produced by a process of gene duplication followed by diversification through either point mutation or gene conversion. Deletions, inversions, transpositions and unequal cross are also likely to have played a role. All these types of mutation, on being coupled to selection, have allowed proteins with novel binding properties to be generated over long periods of evolutionary time. T h e immune system is faced with exactly the same sort of challenge -the production of highaffinity, antigen-specific antibodies from initial low-affinity precursors. Just like germline evolution, the somatic evolution of high-affinity binding sites occurs by an iterative alternation of mutation and selection. However, whereas germline evolution occurs over millions of years, the elaboration of a high-affinity antibody from a lowaffinity precursor needs to be achieved in a matter of days. T o achieve this rapid evolution of binding sites, the immune system relies on very high mutation frequencies, rapid cycles of proliferation and intense selective pressure. Normally, very high mutation frequencies would be lethal to the organism, through the generation of too many harmful mutations. T h e immune system tackles this problem by specifically targeting the hypermutational process to the immunoglobulin genes themselves and so, by and large, minimizing the lateral damage.
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Gene diversification strategies
T h e mutational mechanisms that contribute to the evolution of novel proteins can be broadly grouped into two categories. Non-templated mutations such as single nucleotide substitutions can be caused by replication error or base modification. Templated mutations can be generated as a consequence of gene conversion or recombinational processes. T h e same two processes contribute to the diversification of rearranged immunoglobulin genes. In humans and mice, affinity maturation is achieved by somatic hypermutation -a nontemplated mutational process in which single nucleotide substitutions are introduced in and around the rearranged V gene segments [S] .
However, in chickens and rabbits, gene conversion plays a major role in V gene diversification. Thus, in chickens, a family of V pseudogenes are located upstream of the productively rearranged V genes; these V pseudogenes serve to template a patchwork gene conversion process that diversifies the rearranged V gene [6] . Thus it would appear that the gene diversification mechanisms employed in affinity maturation are representative of mechanisms that occurred during gene evolution, although the antibody diversification mechanisms are targeted specifically to the immunoglobulin gene loci.
Somatic hypermutation
Analysis of the nucleotide substitutions that are introduced during affinity maturation into naturally occurring rearranged immunoglobulin genes as well as into immunoglobulin transgenes has served to define the intrinsic features of the mutational process, as well as delineating the cisacting DNA sequences that serve to recruit the mutational mechanism to the immunoglobulin loci themselves. T h e mutations are largely single nucleotide substitutions, with all bases being targetable and each base capable of being mutated to any other base. T h e actual mechanism of mutation recruitment correlates with the presence of linked transcription regulatory elements. Mutation depends upon the transcription enhancer elements in the immuoglobulin gene loci, with the location of the mutation domain being defined by the position of the transcription promoter [l 13. T h u s mutability broadly correlates with transcribability, although the molecular mechanism by which the mutation process is recruited to the immunoglobulin gene loci remains to be elucidated. T h e linkage to transcription could be direct: a factor involved in mutation induction could be attached physically to the elongating RNA polymerase complex [12, 13] . Alternatively, the broad correlation between transcription and mutation might not reflect a causal relationship. They could both, for example, be regulated similarly by chromatin modifications.
Two phases of hypermutation
Many studies of antibody diversity in mice and humans deficient in a variety of DNA repair proteins have been performed in the hope of gleaning insight into the mechanism of immunoglobulin gene diversification. One of the most informative to date has been the analysis of mice deficient in the mismatch recognition protein, mammalian homologue of bacterial MutS mutator protein (MSH2). Mice deficient in MSH2 exhibited a decreased accumulation of mutations within their immunoglobulin V gene segments, but, most intriguingly, the pattern of IgV gene mutations fixed in MSH2-deficient mice is markedly different from that in controls. T h e mutations are much more likely to occur in G / C (as opposed to A / T ) base pairs, and exhibit markedly increased targeting to the intrinsic mutational hotspots [14, 15] . We have previously interpreted this bias as reflecting the fact that somatic hypermutation in mice and humans is normally a two-stage process, with the first stage being a hotspot-biased preferential mutation at G / C , and the second stage [which requires MSH2 (and MSH6)] preferentially targeting A / T pairs and allowing a more even spread of mutation fixation [14, 16] . Analysis of the mutation spectrum in other species (e.g. frogs), as well as in several cell-line models of mutation (see below), suggests that the G/C-biased phase of mutation could be quite widespread.
Hypermutation in cell lines
Until recently, antibody hypermutation could only be studied in vivo : dissection of cis-regulatory elements relied upon experiments using transgenic mice. However, the demonstration that several rounds of hypermutation could be induced by culturing the BL2 Burkitt lymphoma line with T cells and anti-IgM antibody [17] prompted us to screen for Burkitt lymphoma lines that could provide a tractable in vitro model of constitutive hypermutation. Several such cell lines were identified [18, 19] . Interestingly, these lines largely perform only the G/C-biased phase of hypermutation. Studies using one of these cell lines have revealed that hypermutation is associated with the localized generation of sites within the immunoglobulin V (but not the C) domain that are accessible to terminal deoxynucleotidyltransferase in vivo [18] . This suggests that antibody hypermutation is accompanied by localized DNA strand breaks within the IgV domain.
Gene conversion and hypermutation
Whereas human Burkitt lymphoma lines perform somatic hypermutation constitutively, chicken bursal lymphoma lines have been identified which perform immunoglobulin V gene conversion constitutively -albeit at low frequency [20, 21] . Exceptionally, these chicken lines appear to provide suitable hosts for performing targeted gene disruptions [22] , and this has allowed a genetic analysis dissection of the immunoglobulin V gene conversion process. We recently discovered that, in chicken bursal lymphoma lines deficient in genes implicated in homologous recombination (XRCCZ, XRCC3, RADSlB) , the overall pattern of the IgV gene diversification process is shifted from one of low-frequency gene conversion towards one of high-frequency hypermutation [23] . This strongly supports the idea [24, 25] that IgV gene conversion and somatic hypermutation constitute different means of resolving a common lesion within the IgV gene. Presumably by some means of transcription or chromatin linkage to transcriptional chromatin accessibility, lesions are introduced within the IgV gene domain. Thus 
Linkage with switch recombination
Following an encounter with antigen, the IgV gene diversification process that underpins affinity maturation is also accompanied by a switch in the isotype of the expressed antibody from IgM to one of IgG, IgA and IgE. This class-switching occurs by a region-specific recombinational process that is neither homology-directed nor site-specific
[26]. While switch recombination and somatic hypermutation occur at a similar stage of B cell development, they are clearly independent processes; one can take place without the other. Moreover, they target different regions, with hypermutation targeting the IgV gene in both immunoglobulin heavy-and light-chain loci, whereas switch recombination only targets the switch regions (which are located adjacent to the IgV gene) in the heavy-chain locus. Nevertheless, an intimation of parallels between the two processes was unexpectedly revealed by the fact that deficiency in the mismatch recognition protein M S H 2 caused a focusing of both hypermutation and switch recombination towards a similar consensus sequence (GAGCT) [27]. This led us to propose that hypermutation and switch recombination might show similarities in the initial targeting of the two processes, although clearly the resolution of the lesions in the two cases must be distinct -one leading to point mutations and the other to recombination.
Role of act ivat ion4 nd uced cyt id i ne deaminase (AID)
A dramatic demonstration of the validity of the speculation of the parallel between switch recombination and hypermutation was provided by the findings of Honjo and co-workers that deficiency in AID, a B cell-specific protein of unknown molecular function, causes an ablation of both processes in vivo [28-301. Using the chicken bursa1 lymphoma line, we and others have been able to show that A I D is also essential for IgV gene conversion, with results suggesting an active involvement of AID in the initiation of these processes, and not simply in bringing the B lymphocyte to a stage of development where it is competent to carry them out [31,32]. Indeed, Martin et al. [33] have also demonstrated that ectopic provision of A I D can initiate hypermutation in a plasmacytoma cell line. Thus A I D would appear to play a central role in the triggering of all three diversification processes, although the molecular mechanism by which it carries out this role remains to be identified (Figure 3) .
B cell selection
T h e selective processes that allow the generation of high-affinity antibodies must work over a wide affinity range. Following antigen encounter, the B cells available to bind the antigen are likely to have receptors of only low affinity. Nevertheless, these cells must be recognized in a sea of non-binders and selectively expanded. This means that there must be some form of discrimination between binders and non-binders in the low-affinity range. Following a period of expansion and iterative mutation/selection, the selection process must then proceed to operate in the very-high-affinity range, discriminating those binders that have
Figure 4
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excellent characteristics from others that are merely very good. Experiments performed using the model antigen system hen egg lysozyme to delineate the affinity-dependence of the B cell response to a soluble, monomeric antigen have identified that the affinity threshold for triggering a B cell is somewhat below lo6 M-' and that, under the assays conditions used, there is a ceiling for affinity discrimination somewhere in the range (Figure 4 ). A primary repertoire of serum IgM is produced in v i v o , and its production does not require antigen encounter. This contrasts with the production of IgG and IgA in serum (as well as with the production of somatically mutated immunoglobulin), all of which require encounter with antigen [4] (Figure 2 ). The pre-immune IgM is often referred to as natural antibody. It not only affords a first line of innate (as opposed to acquired) immunity against infecting organisms ; it also acts to accelerate the development of the adaptive humoral response [36, 37] . Thus, upon entering the body, an antigen is likely to be complexed with the low-affinity natural antibody. This will allow the antigen to be aggregated, which will serve to increase the avidity of the antigen-B-cell interaction, thereby lowering the threshold affinity needed for B cell activation. Moreover, the IgM-antigen complex will be recognized by the complement system, ligated with complement components and deposited on cell surfaces through binding to complement receptors [38, 39] .
Lowering the affinity threshold
The complement system may also recognize the antigen directly or through other serum components (without need of IgM) and lead to antigen deposition on the surface of various accessory cell types of the immune system. By depositing the antigen on a cell surface, the potential avidity of antigen-B-cell interaction is dramatically enhanced, thereby allowing a substantial lowering of the affinity threshold for B cell activation.
Membrane-arrayed antigen : synapse formation
The arraying of antigen on the cell surface has other implications for the initiation of the immune response. It allows the antigen to be seen not as a free soluble molecule, but in the context of self cell surfaces. The interaction of the antigen receptor on the B cell with antigen arrayed on the target cell causes both antigen and antigen receptor to be gathered together into the region of synapsis [40] . The formation of this synapse is accompanied by a dramatic reorganization of the B cell surface, with changes in the geographical location of various B cell surface molecules. The antigen itself is likely to be tethered to the surface of the displaying cell by various professional presenting receptors (e.g. Fc receptors and the complement receptor CD21). Thus CD21 and the relevant Fc receptor are likely to be recruited into the synapse. This directed cell-surface reorganization provides a mechanism for the selective recruitment to or exclusion from the synapse of specific cell-surface proteins on the B cell or antigen-displaying cells. Indeed, this has already been shown for CD45 and CD22, and doubtless applies to many other cell-surface proteins.
Synapse formation and avoidance of autoimmunity
Apart from generally assisting the regulation of B cell activation, this cellular reorganization will permit context-dependent B cell activation. B cell activation can be regulated such that there is preferential triggering by antigen tethered by professional presenting receptors, rather than B cells being triggered by abundant cell-surface molecules of self. A likely example of such regulation is provided by the role of CD22-a B lymphocyte-specific, cell-surface glycoprotein. CD22 associates with the antigen receptor on B cells and acts to inhibit its activity through the cytoplasmic recruitment of the protein tyrosine 
Antigen extraction
While selective regulation of the affinity threshold for B cell activation probably plays an important role in the avoidance of autoreactivity, the selective provision of T cell help is clearly a major strategy for the avoidance of humoral autoimmune disease. Thus, even if antigen alone can activate a B cell, the full development of high-affinity antibodies requires T cell help. Hence, if a B cell is to respond to membrane-tethered antigen, it must acquire some of that antigen from the displaying cell in order to internalize it, process it and present antigen-derived peptides (in association with M H C molecules) to T cells in order to acquire cognate T cell help. One might imagine that encountering membrane-tethered antigen would present a problem to the B cell with respect to antigen internalization. However, not only are B cells able to acquire membrane-tethered antigen from the presenting cell, they are even able to extract membrane-integral antigens from the target cell [40]. T h e mechanism of this acquisition is unknown (perhaps it involves some form of transcytosis), but it is certainly very efficient, and may be important in allowing B cell activation by low amounts of antigen. Furthermore, the selective extraction of antigen may be of importance in allowing the B cell to internalize only those proteins on the target cell (or organism) that are closely linked to (or part of) the antigen recognized by the receptor on the B cell. This will limit the range of foreign peptides displayed by the B cell, which may be important in the appropriate focusing of T cell help. T h e phenomenon will be reflected by finding that the B cell and T cell epitopes displayed by membrane antigens are often linked, and probably located within the same molecule.
Once the immune response is under way, it will be necessary that affinity discrimination occurs in the higher-affinity range. Presumably, at this stage, the antigen concentration on the presenting cell has diminished substantially and competing antibody will be present in serum. Presumably, in this situation, competition can occur in the high-affinity range.
Antibody generation in vitro
T h e availability of cell lines that constitutively diversify the immunoglobulin genes by hypermutation during culture and which display the resultant immunoglobulin on their surface has allowed us to attempt to mimic aspects of physiological antibody selection in vitro. We have used iterative rounds of mutation/selection to generate and mature high-affinity antibodies. Initially, we used the human Ramos Burkitt lymphoma line, which expresses an IgM of unknown specificity and undergoes constitutive mutation of the encoding V genes during culture. T h e population.
of Ramos cells was incubated with magnetic beads densely coated with streptavidin, in the hope that rare variants in the Ramos population might have acquired V gene mutations that would enable them to bind the streptavidin. By virtue of the high density of streptavidin on the bead, together with the high density of IgM on the Ramos cell surface, we hoped that such binders might be pulled down. Following multiple rounds of selection, a population of Ramos cells was obtained that could bind to the streptavidin beads, although we could find no evidence of streptavidin specificity in the IgM secreted by these cells. It turns out that the binding affinity was simply too low for detection, since variants of the Ramos cells that have been selected on streptavidin beads but which have lost surface IgM also lose streptavidin binding. By performing multiple rounds of selection using (i) beads coated with a lower density of streptavidin, then (ii) soluble streptavidin aggregates, and finally (iii) directly Auoresceinated streptavidin, we have generated a dynasty of
